Annals of Neurology

Cover image for Annals of Neurology

Supplement: Multiple Sclerosis: Approaches to Management

1994

Volume 36, Issue S1

Pages fmi–fmi, S1–S162

  1. Masthead

    1. Top of page
    2. Masthead
    3. Introduction
    4. The Evolution of Multiple Sclerosis
    5. Understanding Etiology/Pathogenesis in Relation to Therapy
    6. Understanding Etiology/Pathogenesis in Relation to Therapys
    7. Definition of Treatment Groups
    8. Treatment Strategies
    9. Managing Individuals with Multiple Sclerosis
    10. Future Prospects
    1. Masthead (page fmi)

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360701

  2. Introduction

    1. Top of page
    2. Masthead
    3. Introduction
    4. The Evolution of Multiple Sclerosis
    5. Understanding Etiology/Pathogenesis in Relation to Therapy
    6. Understanding Etiology/Pathogenesis in Relation to Therapys
    7. Definition of Treatment Groups
    8. Treatment Strategies
    9. Managing Individuals with Multiple Sclerosis
    10. Future Prospects
    1. Introduction (page S1)

      Donald H. Silberg

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360702

  3. The Evolution of Multiple Sclerosis

    1. Top of page
    2. Masthead
    3. Introduction
    4. The Evolution of Multiple Sclerosis
    5. Understanding Etiology/Pathogenesis in Relation to Therapy
    6. Understanding Etiology/Pathogenesis in Relation to Therapys
    7. Definition of Treatment Groups
    8. Treatment Strategies
    9. Managing Individuals with Multiple Sclerosis
    10. Future Prospects
    1. The evolution of multiple sclerosis epidemiology (pages S2–S5)

      Dr Leonard T. Kurland

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360703

    2. Natural history of multiple sclerosis (pages S6–S11)

      Dr Brian G. Weinshenker

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360704

    3. Genetics and multiple sclerosis: An overview (pages S12–S14)

      Dr George C. Ebers

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360705

    4. Human leukocyte antigen studies in multiple sclerosis (pages S15–S17)

      Dr Jan Hillert

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360706

    5. Genetics of multiple sclerosis in British Columbia and throughout Canada (pages S18–S21)

      Dr A. Dessa Sadovnick

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360707

    6. Influence of infection on exacerbations of multiple sclerosis (pages S25–S28)

      Dr Hillel S. Panitch

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360709

    7. Nervous system–immune system interactions and their role in multiple sclerosis (pages S29–S32)

      Dr Ewa Chelmicka-Schorr and Dr Barry G. Arnason

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360710

    8. Trauma and multiple sclerosis (pages S33–S37)

      Dr Leonard T. Kurland

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360711

    9. Pregnancy and multiple sclerosis (pages S38–S41)

      Dr Oded Abramsky

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360712

  4. Understanding Etiology/Pathogenesis in Relation to Therapy

    1. Top of page
    2. Masthead
    3. Introduction
    4. The Evolution of Multiple Sclerosis
    5. Understanding Etiology/Pathogenesis in Relation to Therapy
    6. Understanding Etiology/Pathogenesis in Relation to Therapys
    7. Definition of Treatment Groups
    8. Treatment Strategies
    9. Managing Individuals with Multiple Sclerosis
    10. Future Prospects
    1. Histopathology and the blood–cerebrospinal fluid barrier in multiple sclerosis (pages S42–S46)

      Dr Hans Lassmann, Gerda Suchanek and Kyoko Ozawa

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360713

  5. Understanding Etiology/Pathogenesis in Relation to Therapys

    1. Top of page
    2. Masthead
    3. Introduction
    4. The Evolution of Multiple Sclerosis
    5. Understanding Etiology/Pathogenesis in Relation to Therapy
    6. Understanding Etiology/Pathogenesis in Relation to Therapys
    7. Definition of Treatment Groups
    8. Treatment Strategies
    9. Managing Individuals with Multiple Sclerosis
    10. Future Prospects
    1. Animal models (pages S47–S53)

      Dr Hartmut Wekerle, Kimikazu Kojima, Joseli Lannes-Vieira, Hans Lassmann and Christopher Linington

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360714

    2. The virology of demyelinating diseases (pages S54–S60)

      Dr Richard T. Johnson

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360715

  6. Definition of Treatment Groups

    1. Top of page
    2. Masthead
    3. Introduction
    4. The Evolution of Multiple Sclerosis
    5. Understanding Etiology/Pathogenesis in Relation to Therapy
    6. Understanding Etiology/Pathogenesis in Relation to Therapys
    7. Definition of Treatment Groups
    8. Treatment Strategies
    9. Managing Individuals with Multiple Sclerosis
    10. Future Prospects
    1. Clinical definition for multiple sclerosis treatment trials (pages S73–S79)

      Dr John F. Kurtzke

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360717

    2. Clinical scoring methods for multiple sclerosis (pages S80–S85)

      Dr John H. Noseworthy

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360718

    3. Serial contrast-enhanced magnetic resonance imaging in patients with early relapsing–remitting multiple sclerosis: Implications for treatment trials (pages S86–S90)

      Dr Joseph A. Frank, Lael A. Stone, Mary E. Smith, Paul S. Albert, Heidi Maloni and Henry F. McFarland

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360719

    4. Magnetic resonance in monitoring the treatment of multiple sclerosis (pages S91–S94)

      Dr David H. Miller

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360720

    5. Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis (pages S95–S96)

      Dr Donald W. Paty, David K. B. Li, Joël J.-F. Oger, Lorne Kastrukoff, Robert Koopmans, Elizabeth Tanton and Gou Jun Zhao

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360721

    6. Magnetization transfer in multiple sclerosis (pages S97–S99)

      Dr Robert I. Grossman

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360722

    7. Cerebrospinal fluid (pages S100–S102)

      Dr Tomas Olsson

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360723

  7. Treatment Strategies

    1. Top of page
    2. Masthead
    3. Introduction
    4. The Evolution of Multiple Sclerosis
    5. Understanding Etiology/Pathogenesis in Relation to Therapy
    6. Understanding Etiology/Pathogenesis in Relation to Therapys
    7. Definition of Treatment Groups
    8. Treatment Strategies
    9. Managing Individuals with Multiple Sclerosis
    10. Future Prospects
    1. Rationale for immunotherapy in multiple sclerosis (pages S103–S107)

      Dr John N. Whitaker

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360724

    2. Design strategies in multiple sclerosis clinical trials (pages S108–S112)

      Dr George W. Ellison, Lawrence W. Myers, Barbara D. Leake, M. Ray Mickey, Dershin Ke, Karl Syndulko and Wallace W. Tourtellotte

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360725

    3. Experimental therapy of relapsing–remitting multiple sclerosis with copolymer-1 (pages S115–S117)

      Dr Kenneth P. Johnson

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360727

  8. Managing Individuals with Multiple Sclerosis

    1. Top of page
    2. Masthead
    3. Introduction
    4. The Evolution of Multiple Sclerosis
    5. Understanding Etiology/Pathogenesis in Relation to Therapy
    6. Understanding Etiology/Pathogenesis in Relation to Therapys
    7. Definition of Treatment Groups
    8. Treatment Strategies
    9. Managing Individuals with Multiple Sclerosis
    10. Future Prospects
    1. Therapeutic strategies (page S122)

      Dr Labe C. Scheinberg

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360729

    2. Symptom management in multiple sclerosis (pages S123–S129)

      Dr Randall T. Schapiro

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360730

    3. Rehabilitation in multiple sclerosis (pages S130–S133)

      Dr Jurgen Mertin

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360731

    4. MS COSTAR: A computerized patient record adapted for clinical research purposes (pages S134–S135)

      Dr Donald Paty, Donald Studney, Ken Redekop and Fred Lublin

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360732

    5. Establishment and use of multiple sclerosis registers—EDMUS (pages S136–S139)

      Prof Christian Confavreux

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360733

  9. Future Prospects

    1. Top of page
    2. Masthead
    3. Introduction
    4. The Evolution of Multiple Sclerosis
    5. Understanding Etiology/Pathogenesis in Relation to Therapy
    6. Understanding Etiology/Pathogenesis in Relation to Therapys
    7. Definition of Treatment Groups
    8. Treatment Strategies
    9. Managing Individuals with Multiple Sclerosis
    10. Future Prospects
    1. Protein growth factors as potential therapies for central nervous system demyelinative disorders (pages S140–S142)

      Dr J. B. Grinspan, J. Stern, B. Franceschini, T. Yasuda and D. Pleasure

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360734

    2. Future prospects for the management of multiple sclerosis (pages S146–S150)

      Dr Alastair Compston

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360736

    3. Future prospects in transplantation (pages S151–S156)

      Dr Anne Baron-Van Evercooren

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360737

    4. Prevention strategies for multiple sclerosis (pages S157–S162)

      Dr Stephen L. Hauser

      Article first published online: 8 OCT 2004 | DOI: 10.1002/ana.410360738

SEARCH

SEARCH BY CITATION